{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:51:11Z","timestamp":1790754671076,"version":"4.1.0"},"reference-count":55,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a genetic disease characterized by neutropenia, lymphopenia, susceptibility to infections, and myelokathexis, which describes degenerative changes of mature neutrophils and hyperplasia of bone marrow myeloid cells. Some patients present with hypogammaglobulinemia and\/or refractory warts of skin and genitalia. Congenital cardiac defects constitute uncommon manifestations of the disease. The disorder, which is inherited as an autosomal dominant trait, is caused by heterozygous mutations of the chemokine receptor CXCR4. These mutations lead to an increased sensitivity of neutrophils and lymphocytes to the unique ligand CXCL12 and to an increased accumulation of mature neutrophils in the bone marrow. Despite greatly improved knowledge of the disease, therapeutic choices are insufficient to prevent some of the disease outcomes, such as development of bronchiectasis, anogenital dysplasia, or invasive cancer. The available therapeutic measures aimed at preventing the risk for infection in WHIM patients are discussed. We critically evaluate the diagnostic criteria of WHIM syndrome, particularly when WHIM syndrome should be suspected in patients with congenital neutropenia and lymphopenia despite the absence of hypogammaglobulinemia and\/or warts. Finally, we discuss recent results of trials evaluating plerixafor, a selective antagonist of CXCR4, as a mechanism-oriented strategy for treatment of WHIM patients.<\/jats:p>","DOI":"10.1182\/blood-2017-02-708552","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T19:55:13Z","timestamp":1508874913000},"page":"2491-2498","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":66,"title":["How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome"],"prefix":"10.1182","volume":"130","author":[{"given":"Raffaele","family":"Badolato","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Cliniche e Sperimentali, Universit\u00e0 degli Studi di Brescia, Brescia, Italy;"},{"name":"Istituto di Medicina Molecolare \u201cA. Nocivelli,\u201d Brescia, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Donadieu","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9mato-Oncologie P\u00e9diatrique Registre des neutrop\u00e9nies cong\u00e9nitales, H\u00f4pital Trousseau, Assistance Publique H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the WHIM Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"14","key":"2019111903501806900_B1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM196404022701402","article-title":"\u201cMyelokathexis\u201d\u2014a new form of chronic granulocytopenia. Report of a case","volume":"270","author":"Zuelzer","year":"1964","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111903501806900_B2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/156652411795677963","article-title":"Clinical and genetic features of warts, hypogammaglobulinemia, infections and myelokathexis (WHIM) syndrome","volume":"11","author":"Dotta","year":"2011","journal-title":"Curr Mol Med"},{"issue":"1","key":"2019111903501806900_B3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet"},{"issue":"5","key":"2019111903501806900_B4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9","article-title":"WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies","volume":"91","author":"Gorlin","year":"2000","journal-title":"Am J Med Genet"},{"issue":"2","key":"2019111903501806900_B5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood-2003-10-3532","article-title":"Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome","volume":"104","author":"Gulino","year":"2004","journal-title":"Blood"},{"issue":"6","key":"2019111903501806900_B6","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","article-title":"WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood"},{"issue":"4","key":"2019111903501806900_B7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.exphem.2005.01.001","article-title":"Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome","volume":"33","author":"Kawai","year":"2005","journal-title":"Exp Hematol"},{"issue":"5","key":"2019111903501806900_B8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaci.2008.12.1133","article-title":"Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients","volume":"123","author":"Tassone","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2019111903501806900_B9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2141.2005.05908.x","article-title":"The WHIM syndrome shows a peculiar dysgranulopoiesis: myelokathexis","volume":"132","author":"Latger-Cannard","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111903501806900_B10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am J Hematol"},{"issue":"15","key":"2019111903501806900_B11","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2010-01-265942","article-title":"Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis","volume":"116","author":"McDermott","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111903501806900_B12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI41649","article-title":"CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow","volume":"120","author":"Eash","year":"2010","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111903501806900_B13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000204770","article-title":"Myelokathexis and monocytosis in a patient with gastric cancer","volume":"87","author":"Maran","year":"1992","journal-title":"Acta Haematol"},{"key":"2019111903501806900_B14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-7-71","article-title":"Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry","volume":"7","author":"Beaussant Cohen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2019111903501806900_B15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpeds.2012.05.058","article-title":"Tetralogy of Fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome","volume":"161","author":"Badolato","year":"2012","journal-title":"J Pediatr"},{"issue":"5","key":"2019111903501806900_B16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaci.2012.07.049","article-title":"Warts and all: human papillomavirus in primary immunodeficiencies","volume":"130","author":"Leiding","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2019111903501806900_B17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2011-12-395608","article-title":"WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4","volume":"120","author":"Liu","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111903501806900_B18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2007-07-102103","article-title":"CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome","volume":"112","author":"Lagane","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2019111903501806900_B19","doi-asserted-by":"crossref","first-page":"e8102","DOI":"10.1371\/journal.pone.0008102","article-title":"Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor","volume":"4","author":"McCormick","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"2019111903501806900_B20","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1084\/jem.20160806","article-title":"Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization","volume":"214","author":"Freitas","year":"2017","journal-title":"J Exp Med"},{"issue":"4","key":"2019111903501806900_B21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10875-016-0276-3","article-title":"WHIM syndrome caused by Waldenstr\u00f6m\u2019s macroglobulinemia-associated mutation CXCR4 (L329fs)","volume":"36","author":"Liu","year":"2016","journal-title":"J Clin Immunol"},{"issue":"10","key":"2019111903501806900_B22","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","article-title":"A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia","volume":"81","author":"Dale","year":"1993","journal-title":"Blood"},{"issue":"2","key":"2019111903501806900_B23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111903501806900_B24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3816\/SCT.2006.n.020","article-title":"The Severe Chronic Neutropenia International Registry: 10-year follow-up report","volume":"3","author":"Dale","year":"2006","journal-title":"Support Cancer Ther"},{"issue":"8","key":"2019111903501806900_B25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00277-002-0489-9","article-title":"Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome","volume":"81","author":"Imashuku","year":"2002","journal-title":"Ann Hematol"},{"issue":"1","key":"2019111903501806900_B26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mjd.2001.111337","article-title":"B-cell lymphoma in a patient with WHIM syndrome","volume":"44","author":"Chae","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019111903501806900_B27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jdv.12927","article-title":"Primary cutaneous follicle center lymphoma in a patient with WHIM syndrome","volume":"30","author":"Yoshii","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2019111903501806900_B28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tripleo.2009.08.011","article-title":"WHIM syndrome and oral squamous cell carcinoma","volume":"109","author":"Cipriani","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"10","key":"2019111903501806900_B29","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1582-4934.2010.01210.x","article-title":"AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome","volume":"15","author":"McDermott","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2019111903501806900_B30","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1084\/jem.20130056","article-title":"Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow","volume":"210","author":"Devi","year":"2013","journal-title":"J Exp Med"},{"issue":"18","key":"2019111903501806900_B31","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2011-06-360586","article-title":"The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome","volume":"118","author":"Dale","year":"2011","journal-title":"Blood"},{"issue":"18","key":"2019111903501806900_B32","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2011-07-368084","article-title":"The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome","volume":"118","author":"McDermott","year":"2011","journal-title":"Blood"},{"issue":"15","key":"2019111903501806900_B33","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2013-09-527226","article-title":"A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor","volume":"123","author":"McDermott","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111903501806900_B34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOH.0b013e32831ac557","article-title":"WHIM syndrome: congenital immune deficiency disease","volume":"16","author":"Kawai","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"2019111903501806900_B35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clim.2010.02.006","article-title":"Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome","volume":"135","author":"Mc Guire","year":"2010","journal-title":"Clin Immunol"},{"issue":"1","key":"2019111903501806900_B36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.celrep.2016.08.068","article-title":"Efficient plasma cell differentiation and trafficking require Cxcr4 desensitization","volume":"17","author":"Biajoux","year":"2016","journal-title":"Cell Reports"},{"issue":"5","key":"2019111903501806900_B37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jaci.2005.08.040","article-title":"Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome","volume":"116","author":"Tarzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2019111903501806900_B38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0761-8425(08)71621-8","article-title":"Le syndrome de Whim: une cause exceptionnelle de bronchiectasies diffuses: D\u00e9ficit immunitaire en CXCR4 et suppuration bronchique chronique [in French]","volume":"25","author":"Vinurel","year":"2008","journal-title":"Rev Mal Respir"},{"issue":"5","key":"2019111903501806900_B39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-9343(90)90187-I","article-title":"A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia","volume":"89","author":"Wetzler","year":"1990","journal-title":"Am J Med"},{"issue":"2","key":"2019111903501806900_B40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QCO.0000000000000147","article-title":"New therapeutic options for noncystic fibrosis bronchiectasis","volume":"28","author":"Yap","year":"2015","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"2019111903501806900_B41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pcl.2008.10.014","article-title":"Bronchiectasis in children","volume":"56","author":"Redding","year":"2009","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"2019111903501806900_B42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/crj.12278","article-title":"Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis","volume":"10","author":"Yang","year":"2016","journal-title":"Clin Respir J"},{"issue":"23","key":"2019111903501806900_B43","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2010-03-272096","article-title":"Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients","volume":"116","author":"Tassone","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111903501806900_B44","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2015.01.014","article-title":"Chromothriptic cure of WHIM syndrome","volume":"160","author":"McDermott","year":"2015","journal-title":"Cell"},{"issue":"30","key":"2019111903501806900_B45","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1016\/j.vaccine.2010.04.057","article-title":"A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome","volume":"28","author":"Handisurya","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"2019111903501806900_B46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjh.12574","article-title":"Genetics on a WHIM","volume":"164","author":"Al Ustwani","year":"2014","journal-title":"Br J Haematol"},{"issue":"11","key":"2019111903501806900_B47","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"issue":"3","key":"2019111903501806900_B48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0609.2009.01368.x","article-title":"Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome","volume":"84","author":"Kriv\u00e1n","year":"2010","journal-title":"Eur J Haematol"},{"issue":"6","key":"2019111903501806900_B49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00005-008-0046-x","article-title":"Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome","volume":"56","author":"Siedlar","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"9","key":"2019111903501806900_B50","first-page":"1271","article-title":"The role of a mutation of the CXCR4 gene in WHIM syndrome","volume":"90","author":"Taniuchi","year":"2005","journal-title":"Haematologica"},{"issue":"1","key":"2019111903501806900_B51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0609.2006.00779.x","article-title":"Recurrent CXCR4 sequence variation in a girl with WHIM syndrome","volume":"78","author":"Alapi","year":"2007","journal-title":"Eur J Haematol"},{"issue":"5","key":"2019111903501806900_B52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00043426-199709000-00007","article-title":"Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature","volume":"19","author":"Hord","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"2019111903501806900_B53","first-page":"111","article-title":"Diagnostic de syndrome WHIM \u00e9voqu\u00e9 devant l\u2019observation de my\u00e9lokathexis [in French]","volume":"72","author":"Bock","year":"2014","journal-title":"Ann Biol Clin (Paris)"},{"issue":"3","key":"2019111903501806900_B54","first-page":"178","article-title":"[WHIM syndrome: a case report and literature review]","volume":"51","author":"Chen","year":"2013","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"6","key":"2019111903501806900_B55","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2141.2006.06240.x","article-title":"Stromal-derived factor-1 abolishes constitutive apoptosis of WHIM syndrome neutrophils harbouring a truncating CXCR4 mutation","volume":"134","author":"Sanmun","year":"2006","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/23\/2491\/1404034\/blood708552.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/23\/2491\/1404034\/blood708552.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:28:50Z","timestamp":1719534530000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/23\/2491\/36745\/How-I-treat-warts-hypogammaglobulinemia-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":55,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,12,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-02-708552","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}